Review about the new practical clinical guideline 2019 of brain death in Mexico
DOI:
https://doi.org/10.31157/an.v25i3.252Keywords:
CPG 2019, brain death, observations, ANN 2010 criteriaAbstract
The National Center of Technological Excellence (CENETEC) provides us within the master catalog of Clinical Practice Guidelines GPC-SS-488-19, the new Clinical Practice Guideline (CPG) that is now titled: Brain Death Diagnosis and Potential Management organ donor. With all the current evidence and recommendations that were reviewed by experts in the field, the guide that is titled Brain Death of the CPG 2011 is outdated.
The guide is intended for second and third level doctors of care and establishes that the diagnosis of brain death (BD) can be made by any doctor; however, this may not be so easy, even for the experts mentioned in the guide.
We consider it unfortunate to have excluded BD certification for the pediatric population from the new CPG and only focused on the adult population; This does not make it practical for the purpose of organ donation and transplantation in this age group. So, the 2011 Brain Death CPG will continue in this regard(1).
Having unified the theme of BD with the recommendations of the management of the potential donor favors that health professionals do not fall into the clinical nihilism of "not doing more for the patient with probable brain death" since the viability of the organs is compromised donated for transplant purposes; since not maintaining an adequate temperature, hemodynamic support and oxygenation acceptable in the donor cadaver, has fatal consequences on the viability of donated organs for transplants.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
This work is licensed under a Creative Commons Attribution 4.0 International License.
September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.